-
1
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: Globocan 2008
-
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127(12), 2893-2917 (2010
-
(2010)
Int J. Cancer
, vol.127
, Issue.12
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
Forman, D.4
Mathers, C.5
Parkin, D.M.6
-
2
-
-
84872967522
-
Cancer statistics 2013
-
Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA. Cancer J. Clin. 63(1), 11-30 (2013
-
(2013)
CA. Cancer J. Clin
, vol.63
, Issue.1
, pp. 11-30
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
3
-
-
14944385553
-
Global cancer statistics 2002
-
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA. Cancer J. Clin. 55(2), 74-108 (2005
-
(2005)
CA. Cancer J. Clin
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
4
-
-
33846436108
-
Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (seer) program
-
Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12(1), 20-37 (2007
-
(2007)
Oncologist
, vol.12
, Issue.1
, pp. 20-37
-
-
Hayat, M.J.1
Howlader, N.2
Reichman, M.E.3
Edwards, B.K.4
-
5
-
-
84877358772
-
Stage at diagnosis and colorectal cancer survival in six high-income countries: A populationbased study of patients diagnosed during 2000-2007
-
ICBP Module 1 Working Group
-
Maringe C, Walters S, Rachet B et al.; ICBP Module 1 Working Group Stage at diagnosis and colorectal cancer survival in six high-income countries: A populationbased study of patients diagnosed during 2000-2007. Acta Oncol. 52(5), 919-932 (2013
-
(2013)
Acta Oncol
, vol.52
, Issue.5
, pp. 919-932
-
-
Maringe, C.1
Walters, S.2
Rachet, B.3
-
6
-
-
84856523631
-
Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics results of a german prospective multicentre observational study
-
Mantke R, Schmidt U, Wolff S, Kube R, Lippert H. Incidence of synchronous liver metastases in patients with colorectal cancer in relationship to clinico-pathologic characteristics. Results of a German prospective multicentre observational study. Eur. J. Surg. Oncol. 38(3), 259-265 (2012
-
(2012)
Eur. J. Surg. Oncol
, vol.38
, Issue.3
, pp. 259-265
-
-
Mantke, R.1
Schmidt, U.2
Wolff, S.3
Kube, R.4
Lippert, H.5
-
7
-
-
33748108173
-
Epidemiology and management of liver metastases from colorectal cancer
-
Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann. Surg. 244(2), 254-259 (2006
-
(2006)
Ann. Surg
, vol.244
, Issue.2
, pp. 254-259
-
-
Manfredi, S.1
Lepage, C.2
Hatem, C.3
Coatmeur, O.4
Faivre, J.5
Bouvier, A.M.6
-
8
-
-
77957194333
-
Epidemiology, management and prognosis of colorectal cancer with lung metastases: A 30-year population-based study
-
Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J, Bouvier AM. Epidemiology, management and prognosis of colorectal cancer with lung metastases: A 30-year population-based study. Gut 59(10), 1383-1388 (2010
-
(2010)
Gut
, vol.59
, Issue.10
, pp. 1383-1388
-
-
Mitry, E.1
Guiu, B.2
Cosconea, S.3
Jooste, V.4
Faivre, J.5
Bouvier, A.M.6
-
9
-
-
0035912144
-
Molecular predictors of survival after adjuvant chemotherapy for colon cancer
-
Watanabe T, Wu TT, Catalano PJ et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N. Engl. J. Med. 344(16), 1196-1206 (2001
-
(2001)
N. Engl. J. Med
, vol.344
, Issue.16
, pp. 1196-1206
-
-
Watanabe, T.1
Wu, T.T.2
Catalano, P.J.3
-
10
-
-
33846595479
-
ASCO ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
-
Locker GY, Hamilton S, Harris J et al.; ASCO. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 24(33), 5313-5327 (2006
-
(2006)
J. Clin. Oncol
, vol.24
, Issue.33
, pp. 5313-5327
-
-
Locker, G.Y.1
Hamilton, S.2
Harris, J.3
-
11
-
-
0018077833
-
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer
-
Wanebo HJ, Rao B, Pinsky CM et al. Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N. Engl. J. Med. 299(9), 448-451 (1978
-
(1978)
N. Engl. J. Med
, vol.299
, Issue.9
, pp. 448-451
-
-
Wanebo, H.J.1
Rao, B.2
Pinsky, C.M.3
-
12
-
-
0019217947
-
The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers
-
Goslin R, Steele G Jr, Macintyre J et al. The use of preoperative plasma CEA levels for the stratification of patients after curative resection of colorectal cancers. Ann. Surg. 192(6), 747-751 (1980
-
(1980)
Ann. Surg
, vol.192
, Issue.6
, pp. 747-751
-
-
Goslin, R.1
Steele Jr., G.2
Macintyre, J.3
-
13
-
-
0021356204
-
The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer results from nsabp (national surgical adjuvant breast and bowel project) clinical trials
-
Wolmark N, Fisher B, Wieand HS et al. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clinical trials. Ann. Surg. 199(4), 375-382 (1984
-
(1984)
Ann. Surg
, vol.199
, Issue.4
, pp. 375-382
-
-
Wolmark, N.1
Fisher, B.2
Wieand, H.S.3
-
14
-
-
84878525484
-
Aneuploidy and elevated CEA indicate an increased risk for metachronous metastasis in colorectal cancer
-
Laubert T, Bente V, Freitag-Wolf S et al. Aneuploidy and elevated CEA indicate an increased risk for metachronous metastasis in colorectal cancer. Int. J. Colorectal Dis. 28(6), 767-775 (2013
-
(2013)
Int. J. Colorectal Dis
, vol.28
, Issue.6
, pp. 767-775
-
-
Laubert, T.1
Bente, V.2
Freitag-Wolf, S.3
-
15
-
-
0033504042
-
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
-
discussion 318
-
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann. Surg. 230(3), 309-18; discussion 318 (1999
-
(1999)
Ann. Surg
, vol.230
, Issue.3
, pp. 309-318
-
-
Fong, Y.1
Fortner, J.2
Sun, R.L.3
Brennan, M.F.4
Blumgart, L.H.5
-
16
-
-
0029881854
-
Surgical resection of colorectal carcinoma metastases to the liver a prognostic scoring system to improve case selection, based on 1568 patients association française de chirurgie
-
Nordlinger B, Guiguet M, Vaillant JC et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 77(7), 1254-1262 (1996
-
(1996)
Cancer
, vol.77
, Issue.7
, pp. 1254-1262
-
-
Nordlinger, B.1
Guiguet, M.2
Vaillant, J.C.3
-
17
-
-
0041160895
-
The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer
-
Wichmann MW, Müller C, Lau-Werner U et al. The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer. Langenbecks. Arch. Surg. 385(4), 271-275 (2000
-
(2000)
Langenbecks. Arch. Surg
, vol.385
, Issue.4
, pp. 271-275
-
-
Wichmann, M.W.1
Müller, C.2
Lau-Werner, U.3
-
18
-
-
33644696421
-
American society of clinical oncology colorectal cancer surveillance: 2005 update of an american society of clinical oncology practice guideline
-
Desch CE, Benson AB 3rd, Somerfield MR et al.; American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J. Clin. Oncol. 23(33), 8512-8519 (2005
-
(2005)
J. Clin. Oncol
, vol.23
, Issue.33
, pp. 8512-8519
-
-
Desch, C.E.1
Benson III, A.B.2
Somerfield, M.R.3
-
19
-
-
24744451447
-
Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer
-
Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest. 23(4), 338-351 (2005
-
(2005)
Cancer Invest
, vol.23
, Issue.4
, pp. 338-351
-
-
Goldstein, M.J.1
Mitchell, E.P.2
-
20
-
-
33846620129
-
Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: A receiver operating characteristic curve analysis
-
Körner H, Söreide K, Stokkeland PJ, Söreide JA. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: A receiver operating characteristic curve analysis. Ann. Surg. Oncol. 14(2), 417-423 (2007
-
(2007)
Ann. Surg. Oncol
, vol.14
, Issue.2
, pp. 417-423
-
-
Körner, H.1
Söreide, K.2
Stokkeland, P.J.3
Söreide, J.A.4
-
21
-
-
0035104009
-
CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA
-
Hanke B, Riedel C, Lampert S et al. CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA). Ann. Oncol. 12(2), 221-226 (2001
-
(2001)
Ann. Oncol
, vol.12
, Issue.2
, pp. 221-226
-
-
Hanke, B.1
Riedel, C.2
Lampert, S.3
-
22
-
-
0031804961
-
DNA mismatch repair and cancer
-
Prolla TA. DNA mismatch repair and cancer. Curr. Opin. Cell Biol. 10(3), 311-316 (1998
-
(1998)
Curr. Opin. Cell Biol
, vol.10
, Issue.3
, pp. 311-316
-
-
Prolla, T.A.1
-
23
-
-
34548680283
-
DNA mismatch repair and colon cancer
-
Marra G, Jiricny J. DNA mismatch repair and colon cancer. Adv. Exp. Med. Biol. 570, 85-123 (2005
-
(2005)
Adv. Exp. Med. Biol
, vol.570
, pp. 85-123
-
-
Marra, G.1
Jiricny, J.2
-
24
-
-
84869048414
-
Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer
-
Roth AD, Delorenzi M, Tejpar S et al. Integrated analysis of molecular and clinical prognostic factors in stage II/III colon cancer. J. Natl Cancer Inst. 104(21), 1635-1646 (2012
-
(2012)
J. Natl Cancer Inst
, vol.104
, Issue.21
, pp. 1635-1646
-
-
Roth, A.D.1
Delorenzi, M.2
Tejpar, S.3
-
25
-
-
63849088630
-
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer
-
Van Cutsem E, Köhne CH, Hitre E et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N. Engl. J. Med. 360(14), 1408-1417 (2009
-
(2009)
N. Engl. J. Med
, vol.360
, Issue.14
, pp. 1408-1417
-
-
Van Cutsem, E.1
Köhne, C.H.2
Hitre, E.3
-
26
-
-
79956298812
-
Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: Updated analysis of overall survival according to tumor KRAS and BRAF mutation status
-
Van Cutsem E, Köhne CH, Láng I et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: Updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J. Clin. Oncol. 29(15), 2011-2019 (2011
-
(2011)
J. Clin. Oncol
, vol.29
, Issue.15
, pp. 2011-2019
-
-
Van Cutsem, E.1
Köhne, C.H.2
Láng, I.3
-
27
-
-
79956310674
-
Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: The OPUS study
-
Bokemeyer C, Bondarenko I, Hartmann JT et al. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: The OPUS study. Ann. Oncol. 22(7), 1535-1546 (2011
-
(2011)
Ann. Oncol
, vol.22
, Issue.7
, pp. 1535-1546
-
-
Bokemeyer, C.1
Bondarenko, I.2
Hartmann, J.T.3
-
28
-
-
78149250536
-
Randomized, phase iii trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (folfox4) versus folfox4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The prime study
-
Douillard JY, Siena S, Cassidy J et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: The PRIME study. J. Clin. Oncol. 28(31), 4697-4705 (2010
-
(2010)
J. Clin. Oncol
, vol.28
, Issue.31
, pp. 4697-4705
-
-
Douillard, J.Y.1
Siena, S.2
Cassidy, J.3
-
29
-
-
79959337678
-
Mrc coin trial investigators addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised phase 3 mrc coin trial
-
Maughan TS, Adams RA, Smith CG et al.; MRC COIN Trial Investigators. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: Results of the randomised Phase 3 MRC COIN trial. Lancet 377(9783), 2103-2114 (2011
-
(2011)
Lancet
, vol.377
, Issue.9783
, pp. 2103-2114
-
-
Maughan, T.S.1
Adams, R.A.2
Smith, C.G.3
-
30
-
-
84861432557
-
Phase iii trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (nordic flox) versus flox alone in first-line treatment of metastatic colorectal cancer: The nordic-vii study
-
Tveit KM, Guren T, Glimelius B et al. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: The NORDIC-VII study. J. Clin. Oncol. 30(15), 1755-1762 (2012
-
(2012)
J. Clin. Oncol
, vol.30
, Issue.15
, pp. 1755-1762
-
-
Tveit, K.M.1
Guren, T.2
Glimelius, B.3
-
31
-
-
75749102647
-
Prognostic role of kras and braf in stage ii and iii resected colon cancer: Results of the translational study on the petacc-3, eortc 40993, sakk 60-00 trial
-
Roth AD, Tejpar S, Delorenzi M et al. Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: Results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J. Clin. Oncol. 28(3), 466-474 (2010
-
(2010)
J. Clin. Oncol
, vol.28
, Issue.3
, pp. 466-474
-
-
Roth, A.D.1
Tejpar, S.2
Delorenzi, M.3
-
32
-
-
77955277111
-
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis
-
De Roock W, Claes B, Bernasconi D et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis. Lancet Oncol. 11(8), 753-762 (2010
-
(2010)
Lancet Oncol
, vol.11
, Issue.8
, pp. 753-762
-
-
De Roock, W.1
Claes, B.2
Bernasconi, D.3
-
33
-
-
77954215850
-
Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab
-
Tol J, Dijkstra JR, Klomp M et al. Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab. Eur. J. Cancer 46(11), 1997-2009 (2010
-
(2010)
Eur. J. Cancer
, vol.46
, Issue.11
, pp. 1997-2009
-
-
Tol, J.1
Dijkstra, J.R.2
Klomp, M.3
-
34
-
-
84862026304
-
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-Type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
-
Bokemeyer C, Van Cutsem E, Rougier P et al. Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-Type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials. Eur. J. Cancer 48(10), 1466-1475 (2012
-
(2012)
Eur. J. Cancer
, vol.48
, Issue.10
, pp. 1466-1475
-
-
Bokemeyer, C.1
Van Cutsem, E.2
Rougier, P.3
-
35
-
-
84859885193
-
BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: An aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features
-
Pai RK, Jayachandran P, Koong AC et al. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: An aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features. Am. J. Surg. Pathol. 36(5), 744-752 (2012
-
(2012)
Am. J. Surg. Pathol
, vol.36
, Issue.5
, pp. 744-752
-
-
Pai, R.K.1
Jayachandran, P.2
Koong, A.C.3
-
36
-
-
84861863158
-
EGFR-mediated re-Activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib
-
Corcoran RB, Ebi H, Turke AB et al. EGFR-mediated re-Activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib. Cancer Discov. 2(3), 227-235 (2012
-
(2012)
Cancer Discov
, vol.2
, Issue.3
, pp. 227-235
-
-
Corcoran, R.B.1
Ebi, H.2
Turke, A.B.3
-
37
-
-
84873360893
-
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents
-
Mao M, Tian F, Mariadason JM et al. Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents. Clin. Cancer Res. 19(3), 657-667 (2013
-
(2013)
Clin. Cancer Res
, vol.19
, Issue.3
, pp. 657-667
-
-
Mao, M.1
Tian, F.2
Mariadason, J.M.3
-
38
-
-
84863012433
-
Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer
-
Yang H, Higgins B, Kolinsky K et al. Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. Cancer Res. 72(3), 779-789 (2012
-
(2012)
Cancer Res
, vol.72
, Issue.3
, pp. 779-789
-
-
Yang, H.1
Higgins, B.2
Kolinsky, K.3
-
39
-
-
0028321495
-
Allelic loss of chromosome 18q and prognosis in colorectal cancer
-
Jen J, Kim H, Piantadosi S et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med. 331(4), 213-221 (1994
-
(1994)
N. Engl. J. Med
, vol.331
, Issue.4
, pp. 213-221
-
-
Jen, J.1
Kim, H.2
Piantadosi, S.3
-
40
-
-
25144456860
-
A systematic review and meta-Analysis of the relationship between chromosome 18q genotype dcc status and colorectal cancer prognosis
-
Popat S, Houlston RS. A systematic review and meta-Analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur. J. Cancer 41(14), 2060-2070 (2005
-
(2005)
Eur. J. Cancer
, vol.41
, Issue.14
, pp. 2060-2070
-
-
Popat, S.1
Houlston, R.S.2
-
41
-
-
0037010411
-
Ukcccr axis trial collaborators adjuvant x-ray and fluorouracil infusion study dna markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: A molecular study
-
Barratt PL, Seymour MT, Stenning SP et al.; UKCCCR AXIS trial collaborators. Adjuvant X-ray and Fluorouracil Infusion Study. DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: A molecular study. Lancet 360(9343), 1381-1391 (2002
-
(2002)
Lancet
, vol.360
, Issue.9343
, pp. 1381-1391
-
-
Barratt, P.L.1
Seymour, M.T.2
Stenning, S.P.3
-
42
-
-
76749132120
-
Prognostic significance and molecular associations of 18q loss of heterozygosity: A cohort study of microsatellite stable colorectal cancers
-
Ogino S, Nosho K, Irahara N et al. Prognostic significance and molecular associations of 18q loss of heterozygosity: A cohort study of microsatellite stable colorectal cancers. J. Clin. Oncol. 27(27), 4591-4598 (2009
-
(2009)
J. Clin. Oncol
, vol.27
, Issue.27
, pp. 4591-4598
-
-
Ogino, S.1
Nosho, K.2
Irahara, N.3
-
43
-
-
20244365185
-
SMAD4 as a prognostic marker in colorectal cancer
-
Alazzouzi H, Alhopuro P, Salovaara R et al. SMAD4 as a prognostic marker in colorectal cancer. Clin. Cancer Res. 11(7), 2606-2611 (2005
-
(2005)
Clin. Cancer Res
, vol.11
, Issue.7
, pp. 2606-2611
-
-
Alazzouzi, H.1
Alhopuro, P.2
Salovaara, R.3
-
44
-
-
24344444413
-
SMAD4 levels and response to 5-fluorouracil in colorectal cancer
-
Alhopuro P, Alazzouzi H, Sammalkorpi H et al. SMAD4 levels and response to 5-fluorouracil in colorectal cancer. Clin. Cancer Res. 11(17), 6311-6316 (2005
-
(2005)
Clin. Cancer Res
, vol.11
, Issue.17
, pp. 6311-6316
-
-
Alhopuro, P.1
Alazzouzi, H.2
Sammalkorpi, H.3
-
45
-
-
77249140520
-
Antimetastatic role of Smad4 signaling in colorectal cancer
-
e1
-
Zhang B, Halder SK, Kashikar ND et al. Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 138(3), 969-80.e1 (2010
-
(2010)
Gastroenterology
, vol.138
, Issue.3
, pp. 969-980
-
-
Zhang, B.1
Halder, S.K.2
Kashikar, N.D.3
-
46
-
-
0037048331
-
SMAD4 is a predictive marker for 5-fluorouracilbased chemotherapy in patients with colorectal cancer
-
Boulay JL, Mild G, Lowy A et al. SMAD4 is a predictive marker for 5-fluorouracilbased chemotherapy in patients with colorectal cancer. Br. J. Cancer 87(6), 630-634 (2002
-
(2002)
Br. J. Cancer
, vol.87
, Issue.6
, pp. 630-634
-
-
Boulay, J.L.1
Mild, G.2
Lowy, A.3
-
47
-
-
0642306985
-
Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis
-
Xie W, Rimm DL, Lin Y, Shih WJ, Reiss M. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis. Cancer J. 9(4), 302-312 (2003
-
(2003)
Cancer J.
, vol.9
, Issue.4
, pp. 302-312
-
-
Xie, W.1
Rimm, D.L.2
Lin, Y.3
Shih, W.J.4
Reiss, M.5
-
48
-
-
6044259206
-
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
-
Allard WJ, Matera J, Miller MC et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10(20), 6897-6904 (2004
-
(2004)
Clin. Cancer Res
, vol.10
, Issue.20
, pp. 6897-6904
-
-
Allard, W.J.1
Matera, J.2
Miller, M.C.3
-
49
-
-
0021024191
-
Correlation between circulating cancer cells and incidence of metastases
-
Glaves D. Correlation between circulating cancer cells and incidence of metastases. Br. J. Cancer 48(5), 665-673 (1983
-
(1983)
Br. J. Cancer
, vol.48
, Issue.5
, pp. 665-673
-
-
Glaves, D.1
-
50
-
-
0021213017
-
Quantitation of tumorigenic disseminating and arrested cancer cells
-
Mayhew E, Glaves D. Quantitation of tumorigenic disseminating and arrested cancer cells. Br. J. Cancer 50(2), 159-166 (1984
-
(1984)
Br. J. Cancer
, vol.50
, Issue.2
, pp. 159-166
-
-
Mayhew, E.1
Glaves, D.2
-
51
-
-
0034687663
-
Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
-
Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, Munn LL. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood. Proc. Natl Acad. Sci. USA 97(26), 14608-14613 (2000
-
(2000)
Proc. Natl Acad. Sci. USA
, vol.97
, Issue.26
, pp. 14608-14613
-
-
Chang, Y.S.1
Di Tomaso, E.2
McDonald, D.M.3
Jones, R.4
Jain, R.K.5
Munn, L.L.6
-
52
-
-
0020076985
-
Metastatic inefficiency in mice bearing B16 melanomas
-
Weiss L, Mayhew E, Rapp DG, Holmes JC. Metastatic inefficiency in mice bearing B16 melanomas. Br. J. Cancer 45(1), 44-53 (1982
-
(1982)
Br. J. Cancer
, vol.45
, Issue.1
, pp. 44-53
-
-
Weiss, L.1
Mayhew, E.2
Rapp, D.G.3
Holmes, J.C.4
-
53
-
-
0031655802
-
Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases
-
Luzzi KJ, MacDonald IC, Schmidt EE et al. Multistep nature of metastatic inefficiency: Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am. J. Pathol. 153(3), 865-873 (1998
-
(1998)
Am. J. Pathol
, vol.153
, Issue.3
, pp. 865-873
-
-
Luzzi, K.J.1
MacDonald, I.C.2
Schmidt, E.E.3
-
54
-
-
0035138203
-
Apoptosis: An early event in metastatic inefficiency
-
Wong CW, Lee A, Shientag L et al. Apoptosis: An early event in metastatic inefficiency. Cancer Res. 61(1), 333-338 (2001
-
(2001)
Cancer Res
, vol.61
, Issue.1
, pp. 333-338
-
-
Wong, C.W.1
Lee, A.2
Shientag, L.3
-
55
-
-
0026600988
-
Lethal deformation of cancer cells in the microcirculation: A potential rate regulator of hematogenous metastasis
-
Weiss L, Nannmark U, Johansson BR, Bagge U. Lethal deformation of cancer cells in the microcirculation: A potential rate regulator of hematogenous metastasis. Int. J. Cancer 50(1), 103-107 (1992
-
(1992)
Int. J. Cancer
, vol.50
, Issue.1
, pp. 103-107
-
-
Weiss, L.1
Nannmark, U.2
Johansson, B.R.3
Bagge, U.4
-
56
-
-
0027257162
-
Cancer-cell traffic in the liver III Lethal deformation of B16 melanoma cells in liver sinusoids
-
Barbera-Guillem E, Weiss L. Cancer-cell traffic in the liver. III Lethal deformation of B16 melanoma cells in liver sinusoids. Int. J. Cancer 54(5), 880-884 (1993
-
(1993)
Int. J. Cancer
, vol.54
, Issue.5
, pp. 880-884
-
-
Barbera-Guillem, E.1
Weiss, L.2
-
57
-
-
16844378813
-
Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells
-
Berezovskaya O, Schimmer AD, Glinskii AB et al. Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells. Cancer Res. 65(6), 2378-2386 (2005
-
(2005)
Cancer Res
, vol.65
, Issue.6
, pp. 2378-2386
-
-
Berezovskaya, O.1
Schimmer, A.D.2
Glinskii, A.B.3
-
58
-
-
84876948946
-
Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer
-
Chen CL, Mahalingam D, Osmulski P et al. Single-cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT-related genes in metastatic prostate cancer. Prostate 73(8), 813-826 (2013
-
(2013)
Prostate
, vol.73
, Issue.8
, pp. 813-826
-
-
Chen, C.L.1
Mahalingam, D.2
Osmulski, P.3
-
59
-
-
0033972059
-
Intravascular origin of metastasis from the proliferation of endothelium-Attached tumor cells: A new model for metastasis
-
Al-Mehdi AB, Tozawa K, Fisher AB, Shientag L, Lee A, Muschel RJ. Intravascular origin of metastasis from the proliferation of endothelium-Attached tumor cells: A new model for metastasis. Nat. Med. 6(1), 100-102 (2000
-
(2000)
Nat. Med
, vol.6
, Issue.1
, pp. 100-102
-
-
Al-Mehdi, A.B.1
Tozawa, K.2
Fisher, A.B.3
Shientag, L.4
Lee, A.5
Muschel, R.J.6
-
60
-
-
0038418255
-
Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium
-
Glinsky VV, Glinsky GV, Glinskii OV et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res. 63(13), 3805-3811 (2003
-
(2003)
Cancer Res
, vol.63
, Issue.13
, pp. 3805-3811
-
-
Glinsky, V.V.1
Glinsky, G.V.2
Glinskii, O.V.3
-
61
-
-
31144464938
-
Dual-color-coded imaging of viable circulating prostate carcinoma cells reveals genetic exchange between tumor cells in vivo, contributing to highly metastatic phenotypes
-
Glinsky GV, Glinskii AB, Berezovskaya O et al. Dual-color-coded imaging of viable circulating prostate carcinoma cells reveals genetic exchange between tumor cells in vivo, contributing to highly metastatic phenotypes. Cell Cycle 5(2), 191-197 (2006
-
(2006)
Cell Cycle
, vol.5
, Issue.2
, pp. 191-197
-
-
Glinsky, G.V.1
Glinskii, A.B.2
Berezovskaya, O.3
-
62
-
-
70349230857
-
In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential
-
Tome Y, Tsuchiya H, Hayashi K et al. In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential. J. Cell. Biochem. 108(2), 362-367 (2009
-
(2009)
J. Cell. Biochem
, vol.108
, Issue.2
, pp. 362-367
-
-
Tome, Y.1
Tsuchiya, H.2
Hayashi, K.3
-
63
-
-
84860397754
-
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
-
Kallergi G, Papadaki MA, Politaki E, Mavroudis D, Georgoulias V, Agelaki S. Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. Breast Cancer Res. 13(3), R59 (2011
-
(2011)
Breast Cancer Res
, vol.13
, Issue.3
-
-
Kallergi, G.1
Papadaki, M.A.2
Politaki, E.3
Mavroudis, D.4
Georgoulias, V.5
Agelaki, S.6
-
64
-
-
84855987633
-
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
-
Kasimir-Bauer S, Hoffmann O, Wallwiener D, Kimmig R, Fehm T. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells. Breast Cancer Res. 14(1), R15 (2012
-
(2012)
Breast Cancer Res
, vol.14
, Issue.1
-
-
Kasimir-Bauer, S.1
Hoffmann, O.2
Wallwiener, D.3
Kimmig, R.4
Fehm, T.5
-
65
-
-
75449106680
-
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
-
Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R, Kasimir-Bauer S. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res. 11(4), R46 (2009
-
(2009)
Breast Cancer Res
, vol.11
, Issue.4
-
-
Aktas, B.1
Tewes, M.2
Fehm, T.3
Hauch, S.4
Kimmig, R.5
Kasimir-Bauer, S.6
-
66
-
-
80055001749
-
Detection of circulating tumour cells with a hybrid (epithelial/ mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
-
Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, Farace F. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br. J. Cancer 105(9), 1338-1341 (2011
-
(2011)
Br. J. Cancer
, vol.105
, Issue.9
, pp. 1338-1341
-
-
Lecharpentier, A.1
Vielh, P.2
Perez-Moreno, P.3
Planchard, D.4
Soria, J.C.5
Farace, F.6
-
67
-
-
82955187028
-
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
-
Raimondi C, Gradilone A, Naso G et al. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res. Treat. 130(2), 449-455 (2011
-
(2011)
Breast Cancer Res. Treat
, vol.130
, Issue.2
, pp. 449-455
-
-
Raimondi, C.1
Gradilone, A.2
Naso, G.3
-
68
-
-
80051988763
-
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers
-
Armstrong AJ, Marengo MS, Oltean S et al. Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol. Cancer Res. 9(8), 997-1007 (2011
-
(2011)
Mol. Cancer Res
, vol.9
, Issue.8
, pp. 997-1007
-
-
Armstrong, A.J.1
Marengo, M.S.2
Oltean, S.3
-
69
-
-
84873811988
-
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition
-
Yu M, Bardia A, Wittner BS et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 339(6119), 580-584 (2013
-
(2013)
Science
, vol.339
, Issue.6119
, pp. 580-584
-
-
Yu, M.1
Bardia, A.2
Wittner, B.S.3
-
70
-
-
81255205399
-
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis
-
Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20(5), 576-590 (2011
-
(2011)
Cancer Cell
, vol.20
, Issue.5
, pp. 576-590
-
-
Labelle, M.1
Begum, S.2
Hynes, R.O.3
-
71
-
-
84856411831
-
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
-
Khoja L, Backen A, Sloane R et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br. J. Cancer 106(3), 508-516 (2012
-
(2012)
Br. J. Cancer
, vol.106
, Issue.3
, pp. 508-516
-
-
Khoja, L.1
Backen, A.2
Sloane, R.3
-
72
-
-
70349729970
-
Epithelial-mesenchymal transition and cell cooperativity in metastasis
-
Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res. 69(18), 7135-7139 (2009
-
(2009)
Cancer Res
, vol.69
, Issue.18
, pp. 7135-7139
-
-
Tsuji, T.1
Ibaragi, S.2
Hu, G.F.3
-
73
-
-
33645758275
-
Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton
-
Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: Podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 9(4), 261-272 (2006
-
(2006)
Cancer Cell
, vol.9
, Issue.4
, pp. 261-272
-
-
Wicki, A.1
Lehembre, F.2
Wick, N.3
Hantusch, B.4
Kerjaschki, D.5
Christofori, G.6
-
74
-
-
84880270290
-
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
-
Baccelli I, Schneeweiss A, Riethdorf S et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat. Biotechnol. (2013
-
(2013)
Nat. Biotechnol
-
-
Baccelli, I.1
Schneeweiss, A.2
Riethdorf, S.3
-
75
-
-
79953766940
-
Tumour evolution inferred by single-cell sequencing
-
Navin N, Kendall J, Troge J et al. Tumour evolution inferred by single-cell sequencing. Nature 472(7341), 90-94 (2011
-
(2011)
Nature
, vol.472
, Issue.7341
, pp. 90-94
-
-
Navin, N.1
Kendall, J.2
Troge, J.3
-
76
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger M, Rowan AJ, Horswell S et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366(10), 883-892 (2012
-
(2012)
N. Engl. J. Med
, vol.366
, Issue.10
, pp. 883-892
-
-
Gerlinger, M.1
Rowan, A.J.2
Horswell, S.3
-
77
-
-
84876674310
-
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
-
Mostert B, Jiang Y, Sieuwerts AM et al. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue. Int. J. Cancer 133(1), 130-141 (2013
-
(2013)
Int. J. Cancer
, vol.133
, Issue.1
, pp. 130-141
-
-
Mostert, B.1
Jiang, Y.2
Sieuwerts, A.M.3
-
78
-
-
0035433139
-
K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells
-
Thebo JS, Senagore AJ, Krygier S, Luchtefeld MA. K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells. Am. Surg. 67(8), 802-805 (2001
-
(2001)
Am. Surg
, vol.67
, Issue.8
, pp. 802-805
-
-
Thebo, J.S.1
Senagore, A.J.2
Krygier, S.3
Luchtefeld, M.A.4
-
79
-
-
84872048462
-
Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/ PIK3CA in circulating tumor cells of patients with colorectal cancer
-
Gasch C, Bauernhofer T, Pichler M et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/ PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin. Chem. 59(1), 252-260 (2013
-
(2013)
Clin. Chem
, vol.59
, Issue.1
, pp. 252-260
-
-
Gasch, C.1
Bauernhofer, T.2
Pichler, M.3
-
80
-
-
84860356499
-
Biomarkers characterization of circulating tumour cells in breast cancer patients
-
Nadal R, Fernandez A, Sanchez-Rovira P et al. Biomarkers characterization of circulating tumour cells in breast cancer patients. Breast Cancer Res. 14(3), R71 (2012
-
(2012)
Breast Cancer Res
, vol.14
, Issue.3
-
-
Nadal, R.1
Fernandez, A.2
Sanchez-Rovira, P.3
-
81
-
-
84879007968
-
Tumorigenic potential of circulating prostate tumor cells
-
Carvalho FL, Simons BW, Antonarakis ES et al. Tumorigenic potential of circulating prostate tumor cells. Oncotarget 4(3), 413-421 (2013
-
(2013)
Oncotarget
, vol.4
, Issue.3
, pp. 413-421
-
-
Carvalho, F.L.1
Simons, B.W.2
Antonarakis, E.S.3
-
82
-
-
84860601923
-
Single cell profiling of circulating tumor cells: Transcriptional heterogeneity and diversity from breast cancer cell lines
-
Powell AA, Talasaz AH, Zhang H et al. Single cell profiling of circulating tumor cells: Transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS ONE 7(5), e33788 (2012
-
(2012)
PLoS ONE
, vol.7
, Issue.5
-
-
Powell, A.A.1
Talasaz, A.H.2
Zhang, H.3
-
83
-
-
84865139080
-
Compartmental differences of circulating tumor cells in colorectal cancer
-
Rahbari NN, Bork U, Kircher A et al. Compartmental differences of circulating tumor cells in colorectal cancer. Ann. Surg. Oncol. 19(7), 2195-2202 (2012
-
(2012)
Ann. Surg. Oncol
, vol.19
, Issue.7
, pp. 2195-2202
-
-
Rahbari, N.N.1
Bork, U.2
Kircher, A.3
-
84
-
-
84871990259
-
Biologic challenges in the detection of circulating tumor cells
-
Joosse SA, Pantel K. Biologic challenges in the detection of circulating tumor cells. Cancer Res. 73(1), 8-11 (2013
-
(2013)
Cancer Res
, vol.73
, Issue.1
, pp. 8-11
-
-
Joosse, S.A.1
Pantel, K.2
-
85
-
-
67849124183
-
Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer
-
Mostert B, Sleijfer S, Foekens JA, Gratama JW. Circulating tumor cells (CTCs): Detection methods and their clinical relevance in breast cancer. Cancer Treat. Rev. 35(5), 463-474 (2009
-
(2009)
Cancer Treat. Rev
, vol.35
, Issue.5
, pp. 463-474
-
-
Mostert, B.1
Sleijfer, S.2
Foekens, J.A.3
Gratama, J.W.4
-
86
-
-
84855952224
-
Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
-
Patriarca C, Macchi RM, Marschner AK, Mellstedt H. Epithelial cell adhesion molecule expression (CD326) in cancer: A short review. Cancer Treat. Rev. 38(1), 68-75 (2012
-
(2012)
Cancer Treat. Rev
, vol.38
, Issue.1
, pp. 68-75
-
-
Patriarca, C.1
Macchi, R.M.2
Marschner, A.K.3
Mellstedt, H.4
-
87
-
-
67651003100
-
The emerging role of EpCAM in cancer and stem cell signaling
-
Munz M, Baeuerle PA, Gires O. The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 69(14), 5627-5629 (2009
-
(2009)
Cancer Res
, vol.69
, Issue.14
, pp. 5627-5629
-
-
Munz, M.1
Baeuerle, P.A.2
Gires, O.3
-
88
-
-
84876767651
-
Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer
-
Neki K, Kawahara H, Watanabe K, Toyama Y, Akiba T, Yanaga K. Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer. Anticancer Res. 33(4), 1769-1772 (2013
-
(2013)
Anticancer Res
, vol.33
, Issue.4
, pp. 1769-1772
-
-
Neki, K.1
Kawahara, H.2
Watanabe, K.3
Toyama, Y.4
Akiba, T.5
Yanaga, K.6
-
89
-
-
20144385756
-
Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
-
Cristofanilli M, Hayes DF, Budd GT et al. Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol. 23(7), 1420-1430 (2005
-
(2005)
J. Clin. Oncol
, vol.23
, Issue.7
, pp. 1420-1430
-
-
Cristofanilli, M.1
Hayes, D.F.2
Budd, G.T.3
-
90
-
-
49249130844
-
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
-
Cohen SJ, Punt CJ, Iannotti N et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26(19), 3213-3221 (2008
-
(2008)
J. Clin. Oncol
, vol.26
, Issue.19
, pp. 3213-3221
-
-
Cohen, S.J.1
Punt, C.J.2
Iannotti, N.3
-
91
-
-
58149165081
-
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
-
de Bono JS, Scher HI, Montgomery RB et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14(19), 6302-6309 (2008
-
(2008)
Clin. Cancer Res
, vol.14
, Issue.19
, pp. 6302-6309
-
-
De Bono, J.S.1
Scher, H.I.2
Montgomery, R.B.3
-
92
-
-
84873817306
-
Relationship among circulating tumor cells cea and overall survival in patients with metastatic colorectal cancer
-
Aggarwal C, Meropol NJ, Punt CJ et al. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer. Ann. Oncol. 24(2), 420-428 (2013
-
(2013)
Ann. Oncol
, vol.24
, Issue.2
, pp. 420-428
-
-
Aggarwal, C.1
Meropol, N.J.2
Punt, C.J.3
-
93
-
-
84880329544
-
Prognostic value of emt-circulating tumor cells in metastatic breast cancer patients undergoing high-dose chemotherapy with autologous hematopoietic stem cell transplantation
-
Mego M, Gao H, Lee BN et al. Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation. J. Cancer 3, 369-380 (2012
-
(2012)
J. Cancer
, vol.3
, pp. 369-380
-
-
Mego, M.1
Gao, H.2
Lee, B.N.3
-
94
-
-
77954624770
-
Significance of circulating tumor cells detected by the cellsearch system in patients with metastatic breast colorectal and prostate cancer
-
Miller MC, Doyle GV, Terstappen LW. Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer. J. Oncol. 2010, 617421 (2010
-
(2010)
J. Oncol
, vol.2010
, pp. 617421
-
-
Miller, M.C.1
Doyle, G.V.2
Terstappen, L.W.3
-
95
-
-
62649158232
-
Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device
-
Talasaz AH, Powell AA, Huber DE et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device. Proc. Natl Acad. Sci. USA 106(10), 3970-3975 (2009
-
(2009)
Proc. Natl Acad. Sci. USA
, vol.106
, Issue.10
, pp. 3970-3975
-
-
Talasaz, A.H.1
Powell, A.A.2
Huber, D.E.3
-
96
-
-
21244499767
-
Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells
-
Zieglschmid V, Hollmann C, Gutierrez B et al. Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. Anticancer Res. 25(3A), 1803-1810 (2005
-
(2005)
Anticancer Res
, vol.25
, Issue.3 A
, pp. 1803-1810
-
-
Zieglschmid, V.1
Hollmann, C.2
Gutierrez, B.3
-
97
-
-
37549002543
-
Isolation of rare circulating tumour cells in cancer patients by microchip technology
-
Nagrath S, Sequist LV, Maheswaran S et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450(7173), 1235-1239 (2007
-
(2007)
Nature
, vol.450
, Issue.7173
, pp. 1235-1239
-
-
Nagrath, S.1
Sequist, L.V.2
Maheswaran, S.3
-
98
-
-
78649872067
-
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
-
Stott SL, Hsu CH, Tsukrov DI et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl Acad. Sci. USA 107(43), 18392-18397 (2010
-
(2010)
Proc. Natl Acad. Sci. USA
, vol.107
, Issue.43
, pp. 18392-18397
-
-
Stott, S.L.1
Hsu, C.H.2
Tsukrov, D.I.3
-
99
-
-
77957075043
-
Microfluidic sorting and multimodal typing of cancer cells in self-Assembled magnetic arrays
-
Saliba AE, Saias L, Psychari E et al. Microfluidic sorting and multimodal typing of cancer cells in self-Assembled magnetic arrays. Proc. Natl Acad. Sci. USA 107(33), 14524-14529 (2010
-
(2010)
Proc. Natl Acad. Sci. USA
, vol.107
, Issue.33
, pp. 14524-14529
-
-
Saliba, A.E.1
Saias, L.2
Psychari, E.3
-
100
-
-
79954619582
-
High-Throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-Abundance circulating tumor cells using a microfluidic system
-
Dharmasiri U, Njoroge SK, Witek MA et al. High-Throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-Abundance circulating tumor cells using a microfluidic system. Anal. Chem. 83(6), 2301-2309 (2011
-
(2011)
Anal. Chem
, vol.83
, Issue.6
, pp. 2301-2309
-
-
Dharmasiri, U.1
Njoroge, S.K.2
Witek, M.A.3
-
101
-
-
84875970076
-
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells
-
179ra47
-
Ozkumur E, Shah AM, Ciciliano JC et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci. Transl. Med. 5(179), 179ra47 (2013
-
(2013)
Sci. Transl. Med
, vol.5
, Issue.179
-
-
Ozkumur, E.1
Shah, A.M.2
Ciciliano, J.C.3
-
102
-
-
77949360268
-
Well plate-coupled microfluidic devices designed for facile image-based cell adhesion and transmigration assays
-
Conant CG, Schwartz MA, Ionescu-Zanetti C. Well plate-coupled microfluidic devices designed for facile image-based cell adhesion and transmigration assays. J. Biomol. Screen. 15(1), 102-106 (2010
-
(2010)
J. Biomol. Screen
, vol.15
, Issue.1
, pp. 102-106
-
-
Conant, C.G.1
Schwartz, M.A.2
Ionescu-Zanetti, C.3
-
103
-
-
84866509291
-
A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire
-
Saucedo-Zeni N, Mewes S, Niestroj R et al. A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire. Int. J. Oncol. (2012
-
(2012)
Int. J. Oncol
-
-
Saucedo-Zeni, N.1
Mewes, S.2
Niestroj, R.3
-
104
-
-
77952430114
-
Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods
-
Königsberg R, Gneist M, Jahn-Kuch D et al. Circulating tumor cells in metastatic colorectal cancer: Efficacy and feasibility of different enrichment methods. Cancer Lett. 293(1), 117-123 (2010
-
(2010)
Cancer Lett
, vol.293
, Issue.1
, pp. 117-123
-
-
Königsberg, R.1
Gneist, M.2
Jahn-Kuch, D.3
-
105
-
-
3042849126
-
Detection of isolated tumor cells in peripheral blood and in BM: Evaluation of a new enrichment method
-
Naume B, Borgen E, Tøssvik S, Pavlak N, Oates D, Nesland JM. Detection of isolated tumor cells in peripheral blood and in BM: Evaluation of a new enrichment method. Cytotherapy 6(3), 244-252 (2004
-
(2004)
Cytotherapy
, vol.6
, Issue.3
, pp. 244-252
-
-
Naume, B.1
Borgen, E.2
Tøssvik, S.3
Pavlak, N.4
Oates, D.5
Nesland, J.M.6
-
106
-
-
35748973274
-
Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood
-
Tong X, Yang L, Lang JC, Zborowski M, Chalmers JJ. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood. Cytometry B. Clin. Cytom. 72(5), 310-323 (2007
-
(2007)
Cytometry B. Clin. Cytom
, vol.72
, Issue.5
, pp. 310-323
-
-
Tong, X.1
Yang, L.2
Lang, J.C.3
Zborowski, M.4
Chalmers, J.J.5
-
107
-
-
77951922478
-
Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostatespecific antibody
-
Gleghorn JP, Pratt ED, Denning D et al. Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostatespecific antibody. Lab Chip 10(1), 27-29 (2010
-
(2010)
Lab Chip
, vol.10
, Issue.1
, pp. 27-29
-
-
Gleghorn, J.P.1
Pratt, E.D.2
Denning, D.3
-
108
-
-
0033891393
-
Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulatingtumor cells
-
Vona G, Sabile A, Louha M et al. Isolation by size of epithelial tumor cells: A new method for the immunomorphological and molecular characterization of circulatingtumor cells. Am. J. Pathol. 156(1), 57-63 (2000
-
(2000)
Am. J. Pathol
, vol.156
, Issue.1
, pp. 57-63
-
-
Vona, G.1
Sabile, A.2
Louha, M.3
-
109
-
-
80052511419
-
A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
-
Farace F, Massard C, Vimond N et al. A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br. J. Cancer 105(6), 847-853 (2011
-
(2011)
Br. J. Cancer
, vol.105
, Issue.6
, pp. 847-853
-
-
Farace, F.1
Massard, C.2
Vimond, N.3
-
110
-
-
79953251573
-
A new device for rapid isolation by size and characterization of rare circulating tumor cells
-
Desitter I, Guerrouahen BS, Benali-Furet N et al. A new device for rapid isolation by size and characterization of rare circulating tumor cells. Anticancer Res. 31(2), 427-441 (2011
-
(2011)
Anticancer Res
, vol.31
, Issue.2
, pp. 427-441
-
-
Desitter, I.1
Guerrouahen, B.S.2
Benali-Furet, N.3
-
111
-
-
80755172534
-
Detection of E coli O157:H7 by immunomagnetic separation coupled with fluorescence immunoassay
-
Zhu P, Shelton DR, Li S et al. Detection of E. coli O157:H7 by immunomagnetic separation coupled with fluorescence immunoassay. Biosens. Bioelectron. 30(1), 337-341 (2011
-
(2011)
Biosens. Bioelectron
, vol.30
, Issue.1
, pp. 337-341
-
-
Zhu, P.1
Shelton, D.R.2
Li, S.3
-
112
-
-
77958037272
-
Portable filter-based microdevice for detection and characterization of circulating tumor cells
-
Lin HK, Zheng S, Williams AJ et al. Portable filter-based microdevice for detection and characterization of circulating tumor cells. Clin. Cancer Res. 16(20), 5011-5018 (2010
-
(2010)
Clin. Cancer Res
, vol.16
, Issue.20
, pp. 5011-5018
-
-
Lin, H.K.1
Zheng, S.2
Williams, A.J.3
-
113
-
-
73449098612
-
Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients
-
Lu J, Fan T, Zhao Q et al. Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients. Int. J. Cancer 126(3), 669-683 (2010
-
(2010)
Int. J. Cancer
, vol.126
, Issue.3
, pp. 669-683
-
-
Lu, J.1
Fan, T.2
Zhao, Q.3
-
114
-
-
78649737519
-
Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients
-
Tan SJ, Lakshmi RL, Chen P, Lim WT, Yobas L, Lim CT. Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens. Bioelectron. 26(4), 1701-1705 (2010
-
(2010)
Biosens. Bioelectron
, vol.26
, Issue.4
, pp. 1701-1705
-
-
Tan, S.J.1
Lakshmi, R.L.2
Chen, P.3
Lim, W.T.4
Yobas, L.5
Lim, C.T.6
-
115
-
-
84874309411
-
Isolation and retrieval of circulating tumor cells using centrifugal forces
-
Hou HW, Warkiani ME, Khoo BL et al. Isolation and retrieval of circulating tumor cells using centrifugal forces. Sci. Rep. 3, 1259 (2013
-
(2013)
Sci. Rep
, vol.3
, Issue.1259
-
-
Hou, H.W.1
Warkiani, M.E.2
Khoo, B.L.3
-
116
-
-
79961142670
-
Dynamic physical properties of dissociated tumor cells revealed by dielectrophoretic field-flow fractionation
-
Shim S, Gascoyne P, Noshari J, Hale KS. Dynamic physical properties of dissociated tumor cells revealed by dielectrophoretic field-flow fractionation. Integr. Biol. (Camb). 3(8), 850-862 (2011
-
(2011)
Integr. Biol. (Camb
, vol.3
, Issue.8
, pp. 850-862
-
-
Shim, S.1
Gascoyne, P.2
Noshari, J.3
Hale, K.S.4
-
117
-
-
84875793897
-
Correlations between the dielectric properties and exterior morphology of cells revealed by dielectrophoretic field-flow fractionation
-
Gascoyne PR, Shim S, Noshari J, Becker FF, Stemke-Hale K. Correlations between the dielectric properties and exterior morphology of cells revealed by dielectrophoretic field-flow fractionation. Electrophoresis 34(7), 1042-1050 (2013
-
(2013)
Electrophoresis
, vol.34
, Issue.7
, pp. 1042-1050
-
-
Gascoyne, P.R.1
Shim, S.2
Noshari, J.3
Becker, F.F.4
Stemke-Hale, K.5
-
118
-
-
79952265771
-
Cytomorphology of circulating colorectal tumor cells: A small case series
-
Marrinucci D, Bethel K, Lazar D et al. Cytomorphology of circulating colorectal tumor cells: A small case series. J. Oncol. 2010, 861341 (2010
-
(2010)
J. Oncol
, vol.2010
, pp. 861341
-
-
Marrinucci, D.1
Bethel, K.2
Lazar, D.3
-
119
-
-
84863043341
-
Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients
-
Shimada R, Iinuma H, Akahane T, Horiuchi A, Watanabe T. Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients. Oncol. Rep. 27(4), 947-953 (2012
-
(2012)
Oncol. Rep
, vol.27
, Issue.4
, pp. 947-953
-
-
Shimada, R.1
Iinuma, H.2
Akahane, T.3
Horiuchi, A.4
Watanabe, T.5
-
120
-
-
84868632393
-
Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients
-
de Albuquerque A, Kubisch I, Stölzel U et al. Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients. J. Transl. Med. 10, 222 (2012
-
(2012)
J. Transl. Med
, vol.10
, pp. 222
-
-
De Albuquerque, A.1
Kubisch, I.2
Stölzel, U.3
-
121
-
-
33947505827
-
Usefulness and clinical significance of quantitative real-Time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer
-
Iinuma H, Okinaga K, Egami H et al. Usefulness and clinical significance of quantitative real-Time RT-PCR to detect isolated tumor cells in the peripheral blood and tumor drainage blood of patients with colorectal cancer. Int. J. Oncol. 28(2), 297-306 (2006
-
(2006)
Int. J. Oncol
, vol.28
, Issue.2
, pp. 297-306
-
-
Iinuma, H.1
Okinaga, K.2
Egami, H.3
-
122
-
-
33846444679
-
Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma
-
Allen-Mersh TG, McCullough TK, Patel H, Wharton RQ, Glover C, Jonas SK. Role of circulating tumour cells in predicting recurrence after excision of primary colorectal carcinoma. Br. J. Surg. 94(1), 96-105 (2007
-
(2007)
Br. J. Surg
, vol.94
, Issue.1
, pp. 96-105
-
-
Allen-Mersh, T.G.1
McCullough, T.K.2
Patel, H.3
Wharton, R.Q.4
Glover, C.5
Jonas, S.K.6
-
123
-
-
84860571431
-
EPISPOT assay: Detection of viable DTCs/CTCs in solid tumor patients
-
Alix-Panabières C. EPISPOT assay: Detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res. 195, 69-76 (2012
-
(2012)
Recent Results Cancer Res
, vol.195
, pp. 69-76
-
-
Alix-Panabières, C.1
-
124
-
-
84875999237
-
Plastin3 is a novel marker for circulating tumor cells undergoing the epithelialmesenchymal transition and is associated with colorectal cancer prognosis
-
Yokobori T, Iinuma H, Shimamura T et al. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelialmesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res. 73(7), 2059-2069 (2013
-
(2013)
Cancer Res
, vol.73
, Issue.7
, pp. 2059-2069
-
-
Yokobori, T.1
Iinuma, H.2
Shimamura, T.3
-
125
-
-
30644472381
-
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
-
Went P, Vasei M, Bubendorf L et al. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Br. J. Cancer 94(1), 128-135 (2006
-
(2006)
Br. J. Cancer
, vol.94
, Issue.1
, pp. 128-135
-
-
Went, P.1
Vasei, M.2
Bubendorf, L.3
-
126
-
-
84876111096
-
Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
-
Sun YF, Xu Y, Yang XR et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection. Hepatology 57(4), 1458-1468 (2013
-
(2013)
Hepatology
, vol.57
, Issue.4
, pp. 1458-1468
-
-
Sun, Y.F.1
Xu, Y.2
Yang, X.R.3
-
127
-
-
84878196648
-
Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer
-
Pesta M, Fichtl J, Kulda V, Topolcan O, Treska V. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Anticancer Res. 33(5), 2239-2243 (2013
-
(2013)
Anticancer Res
, vol.33
, Issue.5
, pp. 2239-2243
-
-
Pesta, M.1
Fichtl, J.2
Kulda, V.3
Topolcan, O.4
Treska, V.5
-
128
-
-
79952737532
-
Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer
-
Papavasiliou P, Fisher T, Kuhn J, Nemunaitis J, Lamont J. Circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Proc. (Bayl. Univ. Med. Cent). 23(1), 11-14 (2010
-
(2010)
Proc. (Bayl. Univ. Med. Cent
, vol.23
, Issue.1
, pp. 11-14
-
-
Papavasiliou, P.1
Fisher, T.2
Kuhn, J.3
Nemunaitis, J.4
Lamont, J.5
-
129
-
-
74949093965
-
Unique localization of circulating tumor cells in patients with hepatic metastases
-
Jiao LR, Apostolopoulos C, Jacob J et al. Unique localization of circulating tumor cells in patients with hepatic metastases. J. Clin. Oncol. 27(36), 6160-6165 (2009
-
(2009)
J. Clin. Oncol
, vol.27
, Issue.36
, pp. 6160-6165
-
-
Jiao, L.R.1
Apostolopoulos, C.2
Jacob, J.3
-
130
-
-
0033551238
-
Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
-
Klein CA, Schmidt-Kittler O, Schardt JA, Pantel K, Speicher MR, Riethmüller G. Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells. Proc. Natl Acad. Sci. USA 96(8), 4494-4499 (1999
-
(1999)
Proc. Natl Acad. Sci. USA
, vol.96
, Issue.8
, pp. 4494-4499
-
-
Klein, C.A.1
Schmidt-Kittler, O.2
Schardt, J.A.3
Pantel, K.4
Speicher, M.R.5
Riethmüller, G.6
-
131
-
-
18344382135
-
Combined transcriptome and genome analysis of single micrometastatic cells
-
Klein CA, Seidl S, Petat-Dutter K et al. Combined transcriptome and genome analysis of single micrometastatic cells. Nat. Biotechnol. 20(4), 387-392 (2002
-
(2002)
Nat. Biotechnol
, vol.20
, Issue.4
, pp. 387-392
-
-
Klein, C.A.1
Seidl, S.2
Petat-Dutter, K.3
-
132
-
-
42449119330
-
High-resolution array comparative genomic hybridization of single micrometastatic tumor cells
-
Fuhrmann C, Schmidt-Kittler O, Stoecklein NH et al. High-resolution array comparative genomic hybridization of single micrometastatic tumor cells. Nucleic Acids Res. 36(7), e39 (2008
-
(2008)
Nucleic Acids Res
, vol.36
, Issue.7
-
-
Fuhrmann, C.1
Schmidt-Kittler, O.2
Stoecklein, N.H.3
-
133
-
-
79957815376
-
Future medical applications of single-cell sequencing in cancer
-
Navin N, Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med. 3(5), 31 (2011
-
(2011)
Genome Med
, vol.3
, Issue.5
, pp. 31
-
-
Navin, N.1
Hicks, J.2
-
134
-
-
84868709258
-
MRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer
-
Cann GM, Gulzar ZG, Cooper S et al. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS ONE 7(11), e49144 (2012
-
(2012)
PLoS ONE
, vol.7
, Issue.11
-
-
Cann, G.M.1
Gulzar, Z.G.2
Cooper, S.3
-
135
-
-
79953288433
-
Development and applications of single-cell transcriptome analysis
-
Tang F, Lao K, Surani MA. Development and applications of single-cell transcriptome analysis. Nat. Methods 8(Suppl. 4), S6-11 (2011
-
(2011)
Nat. Methods
, vol.8
, Issue.SUPPL.4
-
-
Tang, F.1
Lao, K.2
Surani, M.A.3
-
136
-
-
83255177150
-
Single-cell dissection of transcriptional heterogeneity in human colon tumors
-
Dalerba P, Kalisky T, Sahoo D et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotechnol. 29(12), 1120-1127 (2011
-
(2011)
Nat. Biotechnol
, vol.29
, Issue.12
, pp. 1120-1127
-
-
Dalerba, P.1
Kalisky, T.2
Sahoo, D.3
-
137
-
-
84877865227
-
Complex tumor genomes inferred from single Circulating tumor Cells by array-CGH and next-generation sequencing
-
Heitzer E, Auer M, Gasch C et al. Complex tumor genomes inferred from single Circulating tumor Cells by array-CGH and next-generation sequencing. Cancer Res. 73(10), 2965-2975 (2013
-
(2013)
Cancer Res
, vol.73
, Issue.10
, pp. 2965-2975
-
-
Heitzer, E.1
Auer, M.2
Gasch, C.3
-
138
-
-
84877057770
-
Single-cell analysis and sorting using droplet-based microfluidics
-
Mazutis L, Gilbert J, Ung WL, Weitz DA, Griffiths AD, Heyman JA. Single-cell analysis and sorting using droplet-based microfluidics. Nat. Protoc. 8(5), 870-891 (2013
-
(2013)
Nat. Protoc
, vol.8
, Issue.5
, pp. 870-891
-
-
Mazutis, L.1
Gilbert, J.2
Ung, W.L.3
Weitz, D.A.4
Griffiths, A.D.5
Heyman, J.A.6
-
139
-
-
42649085349
-
Prognostic versus predictive value of biomarkers in oncology
-
Oldenhuis CN, Oosting SF, Gietema JA, de Vries EG. Prognostic versus predictive value of biomarkers in oncology. Eur. J. Cancer 44(7), 946-953 (2008
-
(2008)
Eur. J. Cancer
, vol.44
, Issue.7
, pp. 946-953
-
-
Oldenhuis, C.N.1
Oosting, S.F.2
Gietema, J.A.3
De Vries, E.G.4
-
140
-
-
84885430462
-
Circulating tumor cells in high-risk nonmetastatic colorectal cancer
-
Gazzaniga P, Gianni W, Raimondi C et al. Circulating tumor cells in high-risk nonmetastatic colorectal cancer. Tumour Biol. (2013
-
(2013)
Tumour Biol
-
-
Gazzaniga, P.1
Gianni, W.2
Raimondi, C.3
-
141
-
-
55149102183
-
Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-Analysis
-
Katsuno H, Zacharakis E, Aziz O et al. Does the presence of circulating tumor cells in the venous drainage of curative colorectal cancer resections determine prognosis? A meta-Analysis. Ann. Surg. Oncol. 15(11), 3083-3091 (2008
-
(2008)
Ann. Surg. Oncol
, vol.15
, Issue.11
, pp. 3083-3091
-
-
Katsuno, H.1
Zacharakis, E.2
Aziz, O.3
-
142
-
-
84878828739
-
Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: A meta-Analysis
-
Groot Koerkamp B, Rahbari NN, Büchler MW, Koch M, Weitz J. Circulating Tumor Cells and Prognosis of Patients with Resectable Colorectal Liver Metastases or Widespread Metastatic Colorectal Cancer: A Meta-Analysis. Ann. Surg. Oncol. (2013
-
(2013)
Ann. Surg. Oncol
-
-
Groot Koerkamp, B.1
Rahbari, N.N.2
Büchler, M.W.3
Koch, M.4
Weitz, J.5
-
143
-
-
77950458280
-
Meta-Analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer
-
Rahbari NN, Aigner M, Thorlund K et al. Meta-Analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138(5), 1714-1726 (2010
-
(2010)
Gastroenterology
, vol.138
, Issue.5
, pp. 1714-1726
-
-
Rahbari, N.N.1
Aigner, M.2
Thorlund, K.3
-
144
-
-
67650354361
-
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
-
Cohen SJ, Punt CJ, Iannotti N et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann. Oncol. 20(7), 1223-1229 (2009
-
(2009)
Ann. Oncol
, vol.20
, Issue.7
, pp. 1223-1229
-
-
Cohen, S.J.1
Punt, C.J.2
Iannotti, N.3
-
145
-
-
84864033569
-
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: A spanish cooperative group for the treatment of digestive tumors study
-
Sastre J, Maestro ML, Gómez-España A et al. Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: A Spanish Cooperative Group for the Treatment of Digestive Tumors study. Oncologist 17(7), 947-955 (2012
-
(2012)
Oncologist
, vol.17
, Issue.7
, pp. 947-955
-
-
Sastre, J.1
Maestro, M.L.2
Gómez-España, A.3
-
146
-
-
79955030814
-
Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with dukes' stage b and c colorectal cancer
-
Iinuma H, Watanabe T, Mimori K et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. J. Clin. Oncol. 29(12), 1547-1555 (2011
-
(2011)
J. Clin. Oncol
, vol.29
, Issue.12
, pp. 1547-1555
-
-
Iinuma, H.1
Watanabe, T.2
Mimori, K.3
-
147
-
-
77952419985
-
Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents
-
Tol J, Koopman M, Miller MC et al. Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann. Oncol. 21(5), 1006-1012 (2010
-
(2010)
Ann. Oncol
, vol.21
, Issue.5
, pp. 1006-1012
-
-
Tol, J.1
Koopman, M.2
Miller, M.C.3
-
148
-
-
0035866393
-
DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells
-
Jahr S, Hentze H, Englisch S et al. DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61(4), 1659-1665 (2001
-
(2001)
Cancer Res
, vol.61
, Issue.4
, pp. 1659-1665
-
-
Jahr, S.1
Hentze, H.2
Englisch, S.3
-
149
-
-
84863000299
-
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
-
Diaz LA Jr, Williams RT, Wu J et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486(7404), 537-540 (2012
-
(2012)
Nature
, vol.486
, Issue.7404
, pp. 537-540
-
-
Diaz Jr., L.A.1
Williams, R.T.2
Wu, J.3
-
150
-
-
84862999938
-
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
-
Misale S, Yaeger R, Hobor S et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 486(7404), 532-536 (2012
-
(2012)
Nature
, vol.486
, Issue.7404
, pp. 532-536
-
-
Misale, S.1
Yaeger, R.2
Hobor, S.3
-
151
-
-
0037055554
-
Detection of free-circulating tumor-Associated DNA in plasma of colorectal cancer patients and its association with prognosis
-
Lecomte T, Berger A, Zinzindohoué F et al. Detection of free-circulating tumor-Associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int. J. Cancer 100(5), 542-548 (2002
-
(2002)
Int. J. Cancer
, vol.100
, Issue.5
, pp. 542-548
-
-
Lecomte, T.1
Berger, A.2
Zinzindohoué, F.3
-
152
-
-
84877806778
-
Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer
-
Heitzer E, Auer M, Hoffmann EM et al. Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. Int. J. Cancer 133(2), 346-356 (2013
-
(2013)
Int. J. Cancer
, vol.133
, Issue.2
, pp. 346-356
-
-
Heitzer, E.1
Auer, M.2
Hoffmann, E.M.3
-
153
-
-
84873113736
-
Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats
-
García-Olmo DC, Picazo MG, Toboso I, Asensio AI, García-Olmo D. Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats. Mol. Cancer 12, 8 (2013
-
(2013)
Mol. Cancer
, vol.12
, pp. 8
-
-
García-Olmo, D.C.1
Picazo, M.G.2
Toboso, I.3
Asensio, A.I.4
García-Olmo, D.5
-
154
-
-
84891740745
-
Prospective evaluation of methylated sept9 in plasma for detection of asymptomatic colorectal cancer
-
For The PRESEPT Clinical Study Steering Committee Investigators And Study Team
-
Church TR, Wandell M, Lofton-Day C et al.; for the PRESEPT Clinical Study Steering Committee, Investigators and Study Team. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut (2013
-
(2013)
Gut
-
-
Church, T.R.1
Wandell, M.2
Lofton-Day, C.3
-
155
-
-
83355163991
-
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer
-
Warren JD, Xiong W, Bunker AM et al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med. 9, 133 (2011
-
(2011)
BMC Med
, vol.9
, pp. 133
-
-
Warren, J.D.1
Xiong, W.2
Bunker, A.M.3
-
156
-
-
56649094216
-
Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay
-
Grützmann R, Molnar B, Pilarsky C et al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS ONE 3(11), e3759 (2008
-
(2008)
PLoS ONE
, vol.3
, Issue.11
-
-
Grützmann, R.1
Molnar, B.2
Pilarsky, C.3
-
157
-
-
10744233937
-
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
-
Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J. Natl. Cancer Inst. 96(4), 261-268 (2004
-
(2004)
J. Natl. Cancer Inst
, vol.96
, Issue.4
, pp. 261-268
-
-
Umar, A.1
Boland, C.R.2
Terdiman, J.P.3
-
158
-
-
76349103272
-
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
-
Ameri K, Luong R, Zhang H et al. Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype. Br. J. Cancer 102(3), 561-569 (2010
-
(2010)
Br. J. Cancer
, vol.102
, Issue.3
, pp. 561-569
-
-
Ameri, K.1
Luong, R.2
Zhang, H.3
-
159
-
-
84862234603
-
A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells
-
Kang JH, Krause S, Tobin H, Mammoto A, Kanapathipillai M, Ingber DE. A combined micromagnetic-microfluidic device for rapid capture and culture of rare circulating tumor cells. Lab Chip 12(12), 2175-2181 (2012
-
(2012)
Lab Chip
, vol.12
, Issue.12
, pp. 2175-2181
-
-
Kang, J.H.1
Krause, S.2
Tobin, H.3
Mammoto, A.4
Kanapathipillai, M.5
Ingber, D.E.6
-
160
-
-
79952770095
-
Circulating tumour cells: Their utility in cancer management and predicting outcomes
-
Krebs MG, Hou JM, Ward TH, Blackhall FH, Dive C. Circulating tumour cells: Their utility in cancer management and predicting outcomes. Ther. Adv. Med. Oncol. 2(6), 351-365 (2010
-
(2010)
Ther. Adv. Med. Oncol
, vol.2
, Issue.6
, pp. 351-365
-
-
Krebs, M.G.1
Hou, J.M.2
Ward, T.H.3
Blackhall, F.H.4
Dive, C.5
-
161
-
-
45849089879
-
Exploring the role of cancer stem cells in radioresistance
-
Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat. Rev. Cancer 8(7), 545-554 (2008
-
(2008)
Nat. Rev. Cancer
, vol.8
, Issue.7
, pp. 545-554
-
-
Baumann, M.1
Krause, M.2
Hill, R.3
-
162
-
-
33750313208
-
Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells
-
Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 66(19), 9339-9344 (2006
-
(2006)
Cancer Res
, vol.66
, Issue.19
, pp. 9339-9344
-
-
Clarke, M.F.1
Dick, J.E.2
Dirks, P.B.3
-
163
-
-
42949150219
-
Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer
-
Stoecklein NH, Hosch SB, Bezler M et al. Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection
-
(2008)
Cancer Cell
, vol.13
, Issue.5
, pp. 441-453
-
-
Stoecklein, N.H.1
Hosch, S.B.2
Bezler, M.3
-
164
-
-
80051549354
-
Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases
-
Rahbari NN, Reissfelder C, Mühlbayer M et al. Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastases. Ann. Surg. Oncol. 18(8), 2182-2191 (2011
-
(2011)
Ann. Surg. Oncol
, vol.18
, Issue.8
, pp. 2182-2191
-
-
Rahbari, N.N.1
Reissfelder, C.2
Mühlbayer, M.3
-
165
-
-
84865803081
-
Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA
-
Gorges TM, Schiller J, Schmitz A et al. Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA. Biomarkers 17(6), 498-506 (2012
-
(2012)
Biomarkers
, vol.17
, Issue.6
, pp. 498-506
-
-
Gorges, T.M.1
Schiller, J.2
Schmitz, A.3
-
166
-
-
84857076207
-
Quantitative cell-free DNA KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan
-
Spindler KL, Pallisgaard N, Vogelius I, Jakobsen A. Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan. Clin. Cancer Res. 18(4), 1177-1185 (2012
-
(2012)
Clin. Cancer Res
, vol.18
, Issue.4
, pp. 1177-1185
-
-
Spindler, K.L.1
Pallisgaard, N.2
Vogelius, I.3
Jakobsen, A.4
-
167
-
-
84861512882
-
Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients
-
Levy M, Benesova L, Lipska L et al. Utility of cell-free tumour DNA for post-surgical follow-up of colorectal cancer patients. Anticancer Res. 32(5), 1621-1626 (2012
-
(2012)
Anticancer Res
, vol.32
, Issue.5
, pp. 1621-1626
-
-
Levy, M.1
Benesova, L.2
Lipska, L.3
-
168
-
-
64249099411
-
-
7th Edition). Edge SB Byrd DR Compton CC Fritz AG Greene FL Trotti A (Eds Springer, NY, USA
-
AJCC Cancer Staging Manual (7th Edition). Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (Eds). Springer, NY, USA (2010
-
(2010)
AJCC Cancer Staging Manual
-
-
|